Efficacy and Safety of Transurethral Alprostadil Therapy in Men With Erectile Dysfunction

  • Williams, G.
  • Abbou, C.-C.
  • Amar, E. T.
  • Desvaux, P.
  • Flam, T. A.
  • Lychklama a Nijeholt, G. A. B.
  • Lynch, S. F.
  • Morgan, R. J.
  • Muller, S. C.
  • Porst, H.
  • Pryor, J. P.
  • Ryan, P.
  • Witzsch, U. K. F.
  • Hall, M. M.
  • Place, V. A.
  • Spivack, A. P.
  • Gesundheit, N.

  • On Behalf of the MUSE Study Group; Department of Surgery, Hammersmith Hospital, Urology Department, Royal Free Hospital and Middlesex Hospital, London, United Kingdom, Service d'Urologie, Hopital Henri Mondor, Creteil, Chirurgie Urologique et Andrologique, Laboratoire d'Explorations Fonctionnelles et Vascularies, Hopital Tenon and Hopital Cochin, Paris, France, Department of Urology, Academisch Ziekenhuis Leiden, Leiden, The Netherlands, Surgery, Clane, County Kildare and Cork Clinic, Cork, Ireland, Rheinische Friedrich-Wilhelms-Universitat, Bonn and Hamburg, and Dr. Horst Schmidt Kliniken, Weisbaden, Germany, and Department of Clinical Research, VIVUS, Inc., Menlo Park, California

Journal of Urology 161(2):p 725, February 1999.
Copyright © 1999 by the American Urological Association, Inc.
View full text|Download PDF